Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
Condition:   Dyslipidemia Associated With Type II Diabetes Mellitus Interventions:   Drug: Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose;   Drug: Atorvastatin (Lipitor ®) Sponsor:   Laboratorios Silanes S.A. de C.V. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2021 Category: Research Source Type: clinical trials

Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control Trial
Condition:   Hyperbilirubinemia, Neonatal Intervention:   Drug: Fenofibrate Capsules Sponsor:   Shaheed Zulfiqar Ali Bhutto Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2021 Category: Research Source Type: clinical trials